BEGIN:VCALENDAR VERSION:2.0 PRODID:-//171.67.215.200//NONSGML kigkonsult.se iCalcreator 2.26.9// CALSCALE:GREGORIAN METHOD:PUBLISH X-FROM-URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar X-WR-TIMEZONE:America/Los_Angeles BEGIN:VTIMEZONE TZID:America/Los_Angeles X-LIC-LOCATION:America/Los_Angeles BEGIN:STANDARD DTSTART:20231105T020000 TZOFFSETFROM:-0700 TZOFFSETTO:-0800 RDATE:20241103T020000 TZNAME:PST END:STANDARD BEGIN:DAYLIGHT DTSTART:20240310T020000 TZOFFSETFROM:-0800 TZOFFSETTO:-0700 RDATE:20250309T020000 TZNAME:PDT END:DAYLIGHT END:VTIMEZONE BEGIN:VEVENT UID:ai1ec-2677@web.stanford.edu/group/radweb/cgi-bin/radcalendar DTSTAMP:20240330T065836Z CATEGORIES;LANGUAGE=en-US:Canary Center CONTACT:Ashley Williams\; ashleylw@stanford.edu\; https://www.earlydetectio nresearch.com/ DESCRIPTION:Cancer Research UK\, OHSU Knight Cancer Institute and the Canar y Center at Stanford\, present the Early Detection of Cancer Conference se ries. The annual Conference brings together experts in early detection fro m multiple disciplines to share ground breaking research and progress in t he field.\nThe Conference is part of a long-term commitment to invest in e arly detection research\, to understand the biology behind early stage can cers\, find new detection and screening methods\, and enhance uptake and a ccuracy of screening.\nThe 2021 conference will take place October 6-8 vir tually. For more information visit the website: http://earlydetectionresea rch.com/\nTickets: https://www.earlydetectionresearch.com/virtual-experien ce/. DTSTART;VALUE=DATE:20211006 DTEND;VALUE=DATE:20211009 LOCATION:Virtual Event SEQUENCE:0 SUMMARY:Early Detection of Cancer Conference URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/early-de tection-of-cancer-conference-2/ X-COST-TYPE:external X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad calendar/wp-content/uploads/2019/10/EDx21_300x300-150x150.jpg\;150\;150\;1 \,medium\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/wp-cont ent/uploads/2019/10/EDx21_300x300.jpg\;300\;300\; X-ALT-DESC;FMTTYPE=text/html:\\n\\n
\\nCancer Research UK\, OHSU Knight Cancer Institute and the Canary Center at Stanford\, present the Early Detection of Cancer Conference series. The annual Conference brings together experts in early detection from multiple disciplines to share ground breaking res earch and progress in the field.
\nThe Conference is part of a long- term commitment to invest in early detection research\, to understand the biology behind early stage cancers\, find new detection and screening meth ods\, and enhance uptake and accuracy of screening.
\nThe 20 21 conference will take place October 6-8 virtually. For more information visit the website: http://earlydetectionresearch.com/
\nTickets: https://www.earlydetectionresearch.com/virtual- experience/.
X-TICKETS-URL:https://www.earlydetectionresearch.com/virtual-experience/ END:VEVENT BEGIN:VEVENT UID:ai1ec-2417@web.stanford.edu/group/radweb/cgi-bin/radcalendar DTSTAMP:20240330T065836Z CATEGORIES;LANGUAGE=en-US:Canary Center\,IBIIS\,MIPS\,PHIND\,Radiology\,RSL CONTACT:Marta Flory\; flory@stanford.edu DESCRIPTION:Targeted violence continues against Black Americans\, Asian Ame ricans\, and all people of color. The department of radiology diversity co mmittee is running a racial equity challenge to raise awareness of systemi c racism\, implicit bias and related issues. Participants will be provided a list of resources on these topics such as articles\, podcasts\, videos\ , etc.\, from which they can choose\, with the “challenge” of engaging wit h one to three media sources prior to our session (some videos are as shor t as a few minutes). Participants will meet in small-group breakout sessio ns to discuss what they’ve learned and share ideas.\nPlease reach out to M arta Flory\, flory@stanford.edu with questions. For details about the sess ion\, including recommended resources and the Zoom link\, please reach out to Meke Faaoso at mfaaoso@stanford.edu.\nTickets: https://docs.google.com /spreadsheets/d/1ehKqHm32peHcm7NQJ427OaKIa9JpfHVunjBk66etZGc/edit?usp=shar ing. DTSTART;TZID=America/Los_Angeles:20210430T120000 DTEND;TZID=America/Los_Angeles:20210430T130000 LOCATION:Zoom SEQUENCE:0 SUMMARY:Racial Equity Challenge: Race in society URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/racial-e quity-challenge-race-in-society/ X-COST-TYPE:external X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad calendar/wp-content/uploads/2021/04/shield-150x150.png\;150\;150\;1\,mediu m\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/wp-content/upl oads/2021/04/shield.png\;225\;225\; X-ALT-DESC;FMTTYPE=text/html:\\n\\n\\nTargeted violence continues against Black Ameri cans\, Asian Americans\, and all people of color. The department of radiol ogy diversity committee is running a racial equity challenge to raise awar eness of systemic racism\, implicit bias and related issues. Participants will be provided a list of resources on these topics such as articles\, po dcasts\, videos\, etc.\, from which they can choose\, with the “challenge” of engaging with one to three media sources prior to our session (some vi deos are as short as a few minutes). Participants will meet in small-group breakout sessions to discuss what they’ve learned and share ideas.
\n< p>Please reach out to Marta Flory\, fl ory@stanford.edu with questions. For details about the session\, inclu ding recommended resources and the Zoom link\, please reach out to Meke Fa aoso at mfaaoso@stanford.edu.\n X-TICKETS-URL:https://docs.google.com/spreadsheets/d/1ehKqHm32peHcm7NQJ427O aKIa9JpfHVunjBk66etZGc/edit?usp=sharing END:VEVENT BEGIN:VEVENT UID:ai1ec-1757@web.stanford.edu/group/radweb/cgi-bin/radcalendar DTSTAMP:20240330T065836Z CATEGORIES;LANGUAGE=en-US:Canary Center\,Early Cancer Detection Seminar Ser ies CONTACT:Ashley Williams\; ashleylw@stanford.edu\; https://canarycenter.stan ford.edu/seminars.html DESCRIPTION:CEDSS: “Building a Scalable Clinical Genomics Program: How tumo r\, normal\, and plasma DNA sequencing are informing cancer care\, cancer risk\, and cancer detection”\n \nMichael Berger\, Ph.D.\nElizabeth and Fel ix Rohatyn Chair & Associate Director of the Marie-Josée and Henry R. Krav is Center for Molecular Oncology\nMemorial Sloan Kettering Cancer Center\n \nZoom Details\nMeeting URL: https://stanford.zoom.us/s/92559505314\nDial : US: +1 650 724 9799 or +1 833 302 1536 (Toll Free)\nMeeting ID: 925 595 0 5314\nPasscode: 418727\n11:00am – 12:00pm Seminar & Discussion\nRSVP Her e\n \nABSTRACT\nTumor molecular profiling is a fundamental component of pr ecision oncology\, enabling the identification of oncogenomic mutations th at can be targeted therapeutically. To accelerate enrollment to clinical t rials of molecularly targeted agents and guide treatment selection\, we ha ve established a center-wide\, prospective clinical sequencing program at Memorial Sloan Kettering Cancer Center using a custom\, paired tumor-blood normal sequencing assay (MSK-IMPACT)\, which we have used to profile more than 50\,000 patients with solid tumors. Yet beyond just the characteriza tion of tumor-specific alterations\, the inclusion of blood DNA has readil y enabled the identification of germline risk alleles and somatic mutation s associated with clonal hematopoiesis. To complement this approach\, we h ave also implemented a ‘liquid biopsy’ cfDNA panel (MSK-ACCESS) for cancer detection\, surveillance\, and treatment selection and monitoring. In my talk\, I will describe the prevalence of somatic and germline genomic alte rations in a real-world population\, the clinical benefits of cfDNA assess ment\, and how clonal hematopoiesis can inform cancer risk and confound li quid biopsy approaches to cancer detection.\n \nABOUT\nMichael Berger\, Ph D\, holds the Elizabeth and Felix Rohatyn Chair and is Associate Director of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology at Me morial Sloan Kettering Cancer Center\, a multidisciplinary initiative to p romote precision oncology through genomic analysis to guide the diagnosis and treatment of cancer patients. He is also an Associate Attending Geneti cist in the Department of Pathology with expertise in cancer genomics\, co mputational biology\, and high-throughput DNA sequencing technology. His l aboratory is developing experimental and computational methods to characte rize the genetic makeup of individual cancers and identify genomic biomark ers of drug response and resistance. As Scientific Director of Clinical NG S in the Molecular Diagnostics Service\, he oversees the development and b ioinformatics associated with clinical sequencing assays\, and he helped l ead the development and implementation of MSK-IMPACT\, a comprehensive FDA -authorized tumor sequencing panel that been used to profile more than 60\ ,000 tumors from advanced cancer patients at MSK. The resulting data have enabled the characterization of somatic and germline biomarkers across man y cancer types and the identification of mutations associated with clonal hematopoiesis. Dr. Berger also led the development of a clinically validat ed plasma cell-free DNA assay\, MSK-ACCESS\, which his laboratory is using to explore tumor evolution\, acquired drug resistance\, and occult metast atic disease. He received his Bachelor’s Degree in Physics from Princeton University and his Ph.D. in Biophysics from Harvard University.\n \nHosted by: Utkan Demirci\, Ph.D.\nSponsored by: The Canary Center & the Departme nt of Radiology \nStanford University – School of Medicine\nTickets: https ://stanford.zoom.us/webinar/register/5516153318622/WN_MT7TTEciRoWmLVP9GlsJ RA. DTSTART;TZID=America/Los_Angeles:20210511T110000 DTEND;TZID=America/Los_Angeles:20210511T120000 LOCATION:Zoom - See Description for Zoom Link SEQUENCE:0 SUMMARY:Cancer Early Detection Seminar Series – Michael Berger\, Ph.D. URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/cancer-e arly-detection-seminar-series-michael-f-berger-ph-d/ X-COST-TYPE:external X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad calendar/wp-content/uploads/2019/10/berger_160204_07-2_3x2-150x150.jpg\;15 0\;150\;1\,medium\;http://web.stanford.edu/group/radweb/cgi-bin/radcalenda r/wp-content/uploads/2019/10/berger_160204_07-2_3x2-300x200.jpg\;300\;200\ ;1\,large\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/wp-con tent/uploads/2019/10/berger_160204_07-2_3x2.jpg\;600\;400\; X-ALT-DESC;FMTTYPE=text/html:\\n\\n\\nCEDSS: “Building a Scalable Clinical Genomics Program: How tumor\, normal\, and plasma DNA se quencing are informing cancer care\, cancer risk\, and cancer detection” em>
\n\n\n
Elizabeth and Fel
ix Rohatyn Chair & Associate Director of the Marie-Josée and Henry R. Krav
is Center for Molecular Oncology
\nMemorial Sloan Kettering Cancer Ce
nter
\n
Zoom Details
\nMeeti
ng URL: https://stanford.zoom.us/s/92559505314
\nDial: US: +1
650 724 9799 or +1 833 302 1536 (Toll Free)
\nMeeting ID: 925 5950
5314
\nPasscode: 418727
11:00am – 12:00pm Seminar & Discussio
n
\nRSVP Here
\n
ABSTRAC
T
\nTumor molecular profiling is a fundamental component of
precision oncology\, enabling the identification of oncogenomic mutations
that can be targeted therapeutically. To accelerate enrollment to clinical
trials of molecularly targeted agents and guide treatment selection\, we
have established a center-wide\, prospective clinical sequencing program a
t Memorial Sloan Kettering Cancer Center using a custom\, paired tumor-blo
od normal sequencing assay (MSK-IMPACT)\, which we have used to profile mo
re than 50\,000 patients with solid tumors. Yet beyond just the characteri
zation of tumor-specific alterations\, the inclusion of blood DNA has read
ily enabled the identification of germline risk alleles and somatic mutati
ons associated with clonal hematopoiesis. To complement this approach\, we
have also implemented a ‘liquid biopsy’ cfDNA panel (MSK-ACCESS) for canc
er detection\, surveillance\, and treatment selection and monitoring. In m
y talk\, I will describe the prevalence of somatic and germline genomic al
terations in a real-world population\, the clinical benefits of cfDNA asse
ssment\, and how clonal hematopoiesis can inform cancer risk and confound
liquid biopsy approaches to cancer detection.
\n
AB
OUT
\nMichael Berger\, PhD\, holds the Elizabeth and Felix R
ohatyn Chair and is Associate Director of the Marie-Josée and Henry R. Kra
vis Center for Molecular Oncology at Memorial Sloan Kettering Cancer Cente
r\, a multidisciplinary initiative to promote precision oncology through g
enomic analysis to guide the diagnosis and treatment of cancer patients. H
e is also an Associate Attending Geneticist in the Department of Pathology
with expertise in cancer genomics\, computational biology\, and high-thro
ughput DNA sequencing technology. His laboratory is developing experimenta
l and computational methods to characterize the genetic makeup of individu
al cancers and identify genomic biomarkers of drug response and resistance
. As Scientific Director of Clinical NGS in the Molecular Diagnostics Serv
ice\, he oversees the development and bioinformatics associated with clini
cal sequencing assays\, and he helped lead the development and implementat
ion of MSK-IMPACT\, a comprehensive FDA-authorized tumor sequencing panel
that been used to profile more than 60\,000 tumors from advanced cancer pa
tients at MSK. The resulting data have enabled the characterization of som
atic and germline biomarkers across many cancer types and the identificati
on of mutations associated with clonal hematopoiesis. Dr. Berger also led
the development of a clinically validated plasma cell-free DNA assay\, MSK
-ACCESS\, which his laboratory is using to explore tumor evolution\, acqui
red drug resistance\, and occult metastatic disease. He received his Bache
lor’s Degree in Physics from Princeton University and his Ph.D. in Biophys
ics from Harvard University.
\n
Hosted by: Utkan Demirc
i\, Ph.D.
\nSponsored by
: The Canary Center & the Department of Radiology
\nStanfor
d University – School of Medicine
Tickets: https://stanford.zoom.us/webinar/registe r/5516153318622/WN_MT7TTEciRoWmLVP9GlsJRA.
X-TICKETS-URL:https://stanford.zoom.us/webinar/register/5516153318622/WN_MT 7TTEciRoWmLVP9GlsJRA END:VEVENT BEGIN:VEVENT UID:ai1ec-2603@web.stanford.edu/group/radweb/cgi-bin/radcalendar DTSTAMP:20240330T065837Z CATEGORIES;LANGUAGE=en-US:IMMERS Series\,SMMR CONTACT:Steffi Perkins\; slp979@stanford.edu\; https://med.stanford.edu/imm ers/smmr.html DESCRIPTION:Join us for a panel on Behavioral XR on Thursday\, June 3rd fro m 9:00 – 10:30 am PDT. The event will start with a one-hour panel discuss ion featuring Dr. Elizabeth McMahon\, a psychologist with a private practi ce in California\; Sarah Hill of Healium\, a company developing XR apps fo r mental fitness based in Missouri\; Christian Angern of Sympatient\, a co mpany developing VR for anxiety therapy based in Germany\; and Marguerite Manteau-Rao of Penumbra\, a medical device company based in California. T his panel will be moderated by Dr. Walter Greenleaf of Stanford’s Virtual Human Interaction Lab (VHIL) and Dr. Christoph Leuze of the Stanford Medic al Mixed Reality (SMMR) program. Immediately following the panel discussi on\, you are also invited to a 30-minute interactive session with the pane lists where questions and ideas can be explored in real time.\n \nRegister here to save your place now! After registering\, you will receive a conf irmation email containing information about joining the meeting.\n \nPleas e visit this page to subscribe to our events mailing list.\n \nSponsored b y Stanford Medical Mixed Reality (SMMR)\nTickets: https://stanford.zoom.us /meeting/register/tJEvf-ioqTwvHNC2DABwGFESBe71rC6G6qV-. DTSTART;TZID=America/Los_Angeles:20210603T090000 DTEND;TZID=America/Los_Angeles:20210603T103000 LOCATION:Zoom SEQUENCE:0 SUMMARY:IMMERS – Stanford Medical Mixed Reality Panel Discussion Series URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/immers-s tanford-medical-mixed-reality-panel-discussion-series/ X-COST-TYPE:external X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad calendar/wp-content/uploads/2019/10/logo_friendly_small-150x120.png\;150\; 120\;1\,medium\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/w p-content/uploads/2019/10/logo_friendly_small.png\;200\;120\; X-ALT-DESC;FMTTYPE=text/html:\\n\\n\\nJoin us for a panel on Behavior al XR on Thursday\, June 3rd from 9:00 – 10:30 am PDT. The event will start with a one-hour panel discussion featuring Dr. Elizabeth McMahon\, a psychologi st with a private practice in California\; Sarah Hill of Healium\, a company developing XR apps for mental fitness based in Mis souri\; Christian Angern of Sympatient\, a company develo ping VR for anxiety therapy based in Germany\; and Marguerite Manteau-Rao of Penumbra\, a medical device company bas ed in California. This panel will be moderated by Dr. Walter Greenleaf of Stanfor d’s Virtual Human Interaction Lab (VH IL) and Dr. Ch ristoph Leuze of the Stanford Medical Mixed Reality (SMMR) program. Immediately followin g the panel discussion\, you are also invited to a 30-minute interactive s ession with the panelists where questions and ideas can be explored in rea l time.
\n\n
Register here to save your place now! After registering\, you will receive a confirmation email containing information about joining the meeting.
\n\n
Pleas e visit this page to subscribe to our events mailing list.
\n\n
Sponsored by Stanford Medic al Mixed Reality (SMMR)
\nTickets: https://stanford.zoom.us/meeting/register/tJEvf-ioqTw vHNC2DABwGFESBe71rC6G6qV-.
X-TICKETS-URL:https://stanford.zoom.us/meeting/register/tJEvf-ioqTwvHNC2DAB wGFESBe71rC6G6qV- END:VEVENT BEGIN:VEVENT UID:ai1ec-2803@web.stanford.edu/group/radweb/cgi-bin/radcalendar DTSTAMP:20240330T065837Z CATEGORIES;LANGUAGE=en-US:AIMI\,IBIIS\,Radiology\,RSL CONTACT: DESCRIPTION:Radiology Department-Wide Research Meeting\n• Research Announce ments\n• Mirabela Rusu\, PhD – Learning MRI Signatures of Aggressive Prost ate Cancer: Bridging the Gap between Digital Pathologists and Digital Radi ologists\n• Akshay Chaudhari\, PhD – Data-Efficient Machine Learning for M edical Imaging\nLocation: Zoom – Details can be found here: https://radres earch.stanford.edu\nMeetings will be the 3rd Friday of each month.\n \nHos ted by: Kawin Setsompop\, PhD\nSponsored by: the the Department of Radiolo gy DTSTART;TZID=America/Los_Angeles:20210716T120000 DTEND;TZID=America/Los_Angeles:20210716T130000 LOCATION:Zoom – Details can be found here: https://radresearch.stanford.edu SEQUENCE:0 SUMMARY:Radiology-Wide Research Conference URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/radiolog y-wide-research-conference/ X-COST-TYPE:free X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad calendar/wp-content/uploads/2021/07/RWRC-July-150x150.jpeg\;150\;150\;1\,m edium\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/wp-content /uploads/2021/07/RWRC-July-300x195.jpeg\;300\;195\;1\,large\;http://web.st anford.edu/group/radweb/cgi-bin/radcalendar/wp-content/uploads/2021/07/RWR C-July.jpeg\;443\;288\; X-ALT-DESC;FMTTYPE=text/html:\\n\\n\\nRadiology Department-Wide Research Meeting
\n•
Research Announcements
\n• Mirabela Rusu\, PhD – Learning MRI Signat
ures of Aggressive Prostate Cancer: Bridging the Gap between Digital Patho
logists and Digital Radiologists
\n• Akshay Chaudhari\, PhD – Data-Ef
ficient Machine Learning for Medical Imaging
Location: Zoom – Details can be found here: https://radresearch.st
anford.edu
\nMeetings will be the 3rd Friday of each month.
\n
Hosted by: Kawin Setsompop\, PhD
\nSponsore
d by: the the Department of Radiology
CEDSS: The First Cell: A new model for cancer research and treatment
\nAzra Raza\, M.D.
\nChan
Soon-Shiong Professor of Medicine
\nDirector\, Myelodysplastic Syndro
me Center
\nColumbia University Medical Center
\n
L
ocation: Zoom
\nMeeting URL: https:
//stanford.zoom.us/s/99340345860
\nDial: US: +1 650 724 9799 or
+1 833 302 1536 (Toll Free)
\nMeeting ID: 993 4034 5860
\nPassco
de: 711508
ABSTRACT
\nCancer research continues to be predicated on a 1970’s model of research and treatment. Despite half a century of intense research\, we are failing spectacularly to improve the outcome for patients with advanced disease. Those who are cured continue to be treated mostly with the older strategies (surgery-chemo-radiation). Our contention is that the real solution to the cancer problem is to diagn ose cancer early\, at the stage of The First Cell. The rapidly evolving te chnologies are doing much in this area but need to be expanded. We study a pre-leukemic condition called myelodysplastic syndrome (MDS) with the hop e that we can detect the first leukemia cells as the disease transforms to acute myeloid leukemia (AML). Towards this end\, we have collected blood and bone marrow samples on MDS and AML patients since 1984. Today\, our Ti ssue Repository has more than 60\,000 samples. We propose novel methods to identify surrogate markers that can identify the First Cell through study ing the serial samples of patients who evolve from MDS to AML.
\np>\n
ABOUT
\nDr. Raza is a Professor of Medicine and Director of the MDS Center at Columbia University in New York\, NY.She started her research in Myelodisplastic Syndromes (MDS) in 1982 and moved to Rush University\, Chicago\, Illinois in 1992\, where she was the Charl es Arthur Weaver Professor in Oncology and Director\, Division of Myeloid Diseases. The MDS Program\, along with a Tissue Repository containing more than 50\,000 samples from MDS and acute leukemia patients was successfull y relocated to the University of Massachusetts in 2004 and to Columbia Uni versity in 2010.
\nBefore moving to New York\, Dr. Raza was the Chie f of Hematology Oncology and the Gladys Smith Martin Professor of Oncology at the University of Massachussetts in Worcester. She has published the r esults of her laboratory research and clinical trials in prestigious\, pee r reviewed journals such as The New England Journal of Medicine\, Nature\, Blood\, Cancer\, Cancer Research\, British Journal of Hematology\, Leukem ia\, and Leukemia Research. Dr. Raza serves on numerous national and inter national panels as a reviewer\, consultant and advisor and is the recipien t of a number of awards.
\n\n
Hosted by: Utkan Demirci\,
Ph.D.
\nSponsored by: Th
e Canary Center & the Department of Radiology
\nStanford Un
iversity – School of Medicine